Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tirofiban

A non-peptide antiplatelet drug that blocks the glycoprotein IIb/IIIa receptor, preventing fibrinogen from linking platelets together. Approved in the United States in 1998, it is given intravenously in acute coronary syndromes. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?Its design was inspired by echistatin, a small protein in the venom of the saw-scaled viper (Echis carinatus), found from Africa to the Middle East and India, which stops platelets from clumping together.

TirofibanGo to the active ingredient →
TirofibanActive ingredientTirofibanCat. No. P-T133-001CAS 144494-65-5
Tirofiban HClActive ingredientTirofiban HClCat. No. P-T133-002CAS 142373-60-2
Tirofiban-d9Isotopically labelledTirofiban-d9Cat. No. P-T133-004CAS 1332075-40-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.